Shopping News / Articles
markets. businessinsider. com
markets. businessinsider. com > news > stocks > seer-to-showcase-ai-driven-multi-cancer-screening-approach-and-next-generation-proteomics-capabilities-at-asms-2026-1036195409

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

20+ hour, 43+ min ago  (81+ words) Seer Breakfast Symposium ID-free AI Proteomics for Multi-Cancer Screening Date: Monday, June 1, 2026 | Time: 7: 00 a. m. PT | Location: Conference Center, Room 33 B Seer Oral Presentation Building Scalable Proteomics with Radiant DIA" and the Fulcrum Pipeline" Date: Tuesday, June 2, 2026 | Time: 9: 50 a. m. PT | Location: Ballroom 20 BC…...

Symbols: nasdaq:exas,btc-usd
Endpoints News
endpoints. news > asco26-cancer-immunotherapys-magic-bullet-era-is-fading-heres-whats-next

The "search for a magic bullet has faded" in cancer immunotherapy. Here"s what"s next

8+ hour, 55+ min ago  (144+ words) Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these cookies by checking "Do Not Sell or Store My Personal…...

Symbols: nyse:mrk
Hastings Tribune
hastingstribune. com > ap > personal_finance > immuno-cure-deploys-scientist-team-to-manage-research-facility-for-therapeutic-dna-vaccine-for-hiv > article_f6d20a27-a245-5590-bdfc-39bd50a554d9. html

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV at Center of International Innovation for Technology and Science

12+ hour, 30+ min ago  (93+ words) Another significant step towards the success of ICVAX" About the Center of International Innovation for Technology and Science ("CIITS") To learn more about CIITS, please follow the We Chat official account: gh_425f503135d5 Immuno Cure is a clinical-stage biotechnology group headquartered at…...

Symbols: nasdaq:imcr
The Age
theage. com. au > business > companies > perth-biotech-duo-avicena-syngenis-forge-biosecurity-shield-20260527-p60152. html

Perth biotech duo Avicena, Syngenis forge biosecurity shield

17+ hour, 16+ min ago  (655+ words) May 27, 2026 " 11: 32am Two Perth biotechnology companies are positioning themselves at the front line of Australia's future biosecurity defence, combining cutting-edge molecular diagnostics with automated large-scale testing to tackle infectious disease threats before they spread out of control. In an era where…...

Symbols: btc-usd
Dong A Science
dongascience. com > en > news > 78102

KAIST develops light-activated 'Extrabody' antibodies to precisely control immune cells

17+ hour, 59+ min ago  (255+ words) Researchers have developed a 'smart antibody' technology that functions only in response to light or chemical stimuli. This opens the way to precisely control immune cells at the desired time and location. KAIST announced on the 27th that a research team…...

Symbols: btc-usd
The Costa Rica News
thecostaricanews. com > costa-rican-biotech-student-excels-globally-with-innovative-lyme-disease-detection-project

Costa Rican Biotech Student Excels Globally with Innovative Lyme Disease Detection Project " The Costa Rica News

18+ hour, 47+ min ago  (454+ words) Costa Rican Biotech Student Excels Globally with Innovative Lyme Disease Detection Project The Costa Rica News Costa Rican Biotech Student Excels Globally with Innovative Lyme Disease Detection Project CARTAGO, COSTA RICA " Marcel Arrieta Fonseca, a 21-year-old Biotechnology Engineering student at…...

Symbols: nyse:pfe,nasdaq:valn
@lelezard
lelezard. com > en > news-22240454. html

Hoth Therapeutics Awarded U. S. Patent for Cancer-Fighting HT-KIT Oncology Platform

1+ day, 8+ hour ago  (439+ words) Lelezard Hoth Therapeutics Awarded U. S. Patent for Cancer-Fighting HT-KIT Oncology Platform Allowed Claims Cover Composition-of-Matter and Methods Targeting MS4 A6 A Pre-m RNA Splicing to Reduce Surface Expression of the High-Affinity Ig E Receptor (Fc? RI); Strengthens Intellectual Property Foundation Underlying the HT-KIT…...

Symbols: nasdaq:hoth
Eurek Alert!
eurekalert. org > multimedia > 1132814

Filovirus M7 [IMAGE] | Eurek Alert! Science News Releases

1+ day, 3+ hour ago  (177+ words) Sw RI has identified nearly two-dozen pilot antiviral candidates to screen against the Bundibugyo species of the Ebola virus. Sw RI will collaborate with Texas Biomed to test the compounds against Bundibugyo virus in its state-of-the-art Biosafety Level 4 (BSL4) Laboratory. The…...

Symbols: nasdaq:algs
BIOENGINEER. ORG
bioengineer. org > new-study-charts-immune-cells-that-combat-tumors-and-those-that-support-them

New Study Charts Immune Cells That Combat Tumors and Those That Support

1+ day, 3+ hour ago  (1140+ words) Cancer research has long grappled with the complex roles played by immune cells within tumors. While it is well known that tumors are infiltrated by a variety of immune cells, their functions in the cancer microenvironment have remained enigmatic due…...

Symbols: nasdaq:cnsp,bands-1
Harvard Gazette
news. harvard. edu > gazette > story > newsplus > genomic-medicines-fund-awards-five-projects

Genomic Medicines Fund awards five projects

22+ hour, 14+ min ago  (420+ words) The Office of the Vice Provost for Research (OVPR) is pleased to announce that awards have been made to five projects from the Harvard University Genomic Medicines Fund. The fund is intended to support of research involving genome editing that…...

Symbols: nasdaq:rprx
Shopping

Please enter a search for detailed shopping results.